Richard has over 20 years experience in the patent profession, following his time at Oxford University during which he obtained his degree and doctorate in physics and worked as a post-doctoral research assistant in the field of superconductivity (studying both low and high temperature materials). His academic background includes final year modules in electronics and condensed matter physics, and years working as a demonstrator on the electronics practical course for physics undergraduates.
Richard leads a team providing European patent drafting and prosecution services to one of the world's largest mobile telecoms companies, obtaining granted patents at a rate of over two per day in this fast moving field.
Richard and his colleagues have pioneered the use of video conferencing for efficient, successful attendance at EPO Oral Proceedings before the examining division, typically attending around 100 OPs per year.
Richard also has extensive experience advising University and SME clients on IP strategy, and works closely with those clients, providing drafting and prosecution services in addition to support with invention harvesting, to build substantial, commercially-focused patent portfolios, for example in the field of printed and flexible electronics.
BA (Hons) Physics, Oxford University
D.Phil. Physics, Oxford University
Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …Read article
Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …Read article
The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …Read article
Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …Read article
Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …Read article
To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …Read article
HGF in Europe and Knobbe Martens in the US are holding a joint webinar on 9th June. In this webinar we will explore considerations for implementing an effective strategy to …Event details
If you would like to discuss how HGF could help you, contact one of our IP specialists.